Loading…
Chinese testing, inspection and certification (TIC) group serving consumer, industrial and environmental clients.
Chinese testing, inspection and certification (TIC) group serving consumer, industrial and environmental clients.
Charges fees for each test, inspection or certificate, so revenue grows with the volume of products and projects that need compliance, from factory exports to environmental monitoring. Accredited labs are the capital base, and work is spread across manufacturers and government agencies.
In one line: A China-based SGS/Bureau Veritas peer.
Moat: narrow (scale, regulatory licence, brand). Accredited lab network and brand trust are hard to replicate at scale.
Headquarters: Shenzhen, China · Employees: 14,318
Size Centre Testing International (300012.SZ) is a China Industrials company (Miscellaneous Commercial Services) with a market value of $3.96B, the 648th largest of 4,839 China companies the cockpit tracks. Shares closed at CN¥15.71 on 6 Nov 2026.
Performance Over six months the shares fell 5.0%, against +12.6% for the median peer and -16.4% for the China market (cap-weighted) — 4th lowest of 21 in its peer set.
Growth Revenue grew 15.2% over the last twelve months (peer median +7.0%); the operating margin is 16.4% (peer median 10.2%).
Valuation It trades at 22.1× forward earnings against a peer median of 14.4× (6th most expensive of 19).
Price implies For today's price to make sense, revenue must grow about 14% a year for seven years (Req g). Recent delivered growth is +13%, so the hurdle is +1 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 4.3 points above its cost of capital (10.5% WACC).
Next results Next results expected around 16 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥7.34B | CN¥6.60B | CN¥6.07B | CN¥5.59B | CN¥5.12B |
| Revenue growth | — | +9% | +9% | +9% | — |
| Gross profit | CN¥3.87B | CN¥3.07B | CN¥2.88B | CN¥2.58B | CN¥2.42B |
| EBITDA | n/a | CN¥1.57B | CN¥1.43B | CN¥1.33B | CN¥1.34B |
| Net income | CN¥1.16B | CN¥1.02B | CN¥921M | CN¥910M | CN¥903M |
| Free cash flow | CN¥792M | CN¥747M | CN¥388M | CN¥481M | CN¥463M |
| Capital expenditure | CN¥928M | CN¥658M | CN¥691M | CN¥653M | CN¥642M |
| Total debt | CN¥435M | CN¥404M | CN¥361M | CN¥383M | CN¥361M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Centre Testing International 300012.SZ | $3.96B | -5% | +15% | 16% | 22.1× | 14.2% |
| Intertek ITRK.L | $12.3B | +12% | +4% | 18% | 22.3× | 14.8% |
| Sgs SGSN.SW | $24.8B | +21% | +5% | 15% | 24.5× | 3.1% |
| Bureau Veritas BVI.PA | $14.9B | +13% | +2% | 15% | 20.2× | 7.9% |
| Eurofins Scientific ERF.PA | $17.5B | +49% | +3% | 12% | 23.0× | 13.3% |
| UL Solutions ULS | $15.9B | -22% | +6% | 19% | 31.2× | 9.1% |
| GRG Metrology & Test 002967.SZ | $1.72B | -16% | +13% | 13% | 22.7× | 3.9% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 300012.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +10.6% | +3.7% | 8th highest of 21 |
| 6-month return | -5.0% | +12.6% | 4th lowest of 21 |
| Distance from 52-week high | -12.6% | -13.3% | 10th highest of 21 |
| Revenue growth (TTM) | +15.2% | +7.0% | 8th highest of 21 |
| Operating margin | 16.4% | 10.2% | 5th highest of 21 |
| Forward P/E | 22.1× | 14.4× | 6th most expensive of 19 |
| Growth the price implies (Req g, 7 yrs) | 14.2% | 0.1% | 5th most demanding of 18 |
| Growth delivered (Del g) | +13.2% | +9.4% | 7th highest of 18 |
| Hurdle (Req g minus delivered) | +1.0 pp | -9.9 pp | 5th most demanding of 18 |
| ROIC minus cost of capital | +4.3 pp | +3.7 pp | 9th highest of 18 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Centre Testing International 300012.SZ | China | $3.96B | -5% | +15% | 16% | 22.1× | 14.2% | +13.2% |
| PhysicsWallah PWL.NS | India | $4.00B | +18% | +35% | 1% | 100.9× | n/a | n/a |
| SAI Life Sciences SAILIFE.NS | India | $4.02B | +64% | +27% | 21% | 89.2× | n/a | n/a |
| East Buy 1797.HK | Hong Kong | $4.11B | +22% | +34% | 11% | 38.5× | 18.4% | +54.3% |
| Alsok 2331.T | Japan | $3.79B | -1% | +7% | 8% | 13.7× | -6.0% | +4.9% |
| GEO GEO | United States | $3.66B | +28% | +15% | 12% | 13.5× | 6.8% | +2.3% |
| Serco SRP.L | United Kingdom | $3.60B | +5% | +1% | 5% | 14.9× | 1.9% | +4.9% |
| MITIE MTO.L | United Kingdom | $3.56B | +23% | +11% | 3% | 14.2× | 14.1% | +17.6% |
| Loomis LOOMIS.ST | Sweden | $3.46B | +12% | +1% | 11% | 12.6× | -9.1% | +9.7% |
| Brink's BCO | United States | $4.54B | +3% | +7% | 10% | 11.8× | 0.1% | +7.3% |
| MAXIMUS MMS | United States | $3.43B | +2% | -3% | 11% | 7.9× | -8.5% | +9.4% |
| Teleperformance TEP.PA | France | $4.60B | +3% | -3% | 10% | 5.0× | -10.2% | +12.2% |
| Shenzhen Fortune Trend Technology 688318.SS | China | $3.36B | -21% | -3% | 56% | 69.5× | n/a | n/a |
| Dizal Pharmaceutical 688192.SS | China | $4.68B | +18% | +720% | 69% | 9.5× | -8.4% | +95.9% |
| L&T Technology Services LTTS.NS | India | $4.79B | +13% | +2% | 15% | 29.4× | 31.0% | +15.1% |
| Aalberts AALB.AS | Netherlands | $4.87B | +6% | 0% | 10% | 14.6× | 12.9% | +3.4% |
| Jianshe Industry Group (Yunnan) 002265.SZ | China | $3.12B | -11% | +42% | 5% | n/a | 26.3% | +47.9% |
| ABM Industries ABM | United States | $3.10B | +32% | +6% | 5% | 12.5× | -2.0% | +7.9% |
| JHT Design 603061.SS | China | $3.07B | -8% | +93% | 34% | n/a | 43.9% | +30.4% |
| TriNet TNET | United States | $3.05B | +56% | -4% | 6% | 15.1× | -3.3% | +4.4% |
| FTI Consulting FCN | United States | $5.33B | +19% | +8% | 10% | 18.7× | -3.6% | +9.0% |